Literature DB >> 8223659

Imipenem resistance in Enterobacter.

K S Thomson1, C C Sanders, H Chmel.   

Abstract

Blood cultures obtained on two separate occasions from a 37-year-old male who received multiple antibiotics (including imipenem) for treatment of repeated episodes of intraabdominal abscesses and bacteremia yielded two isolates of Enterobacter with reduced susceptibility to imipenem, extended-spectrum cephalosporins, penicillins and aztreonam. Both isolates were unstable, giving rise to different colony types, each of which produced a single, non-inducible Bush group 1 beta-lactamase (pI = 9.6) that hydrolyzed imipenem. Outer membrane proteins were analyzed but no differences were detected between strains with different levels of imipenem resistance. Three-dimensional tests performed in conjunction with disk diffusion susceptibility tests provided a rapid and convenient means of detecting the production of imipenem-hydrolyzing enzymes by the Enterobacter strains. These isolates provided additional evidence that overproduction of the group 1 cephalosporinase of Enterobacter can contribute to resistance to imipenem.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8223659     DOI: 10.1007/bf01973639

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

1.  Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests.

Authors:  K S Thomson; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

2.  Carbapenem resistance in Enterobacter aerogenes is due to lipopolysaccharide alterations.

Authors:  H Leying; W Cullmann; W Dick
Journal:  Chemotherapy       Date:  1991       Impact factor: 2.544

Review 3.  Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

4.  Enhanced resistance to cefotaxime and imipenem associated with outer membrane protein alterations in Enterobacter aerogenes.

Authors:  J M Hopkins; K J Towner
Journal:  J Antimicrob Chemother       Date:  1990-01       Impact factor: 5.790

5.  Characterization of beta-lactamases in situ on polyacrylamide gels.

Authors:  C C Sanders; W E Sanders; E S Moland
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

6.  Biochemical characterization of type A and type B beta-lactamase from Enterobacter cloacae.

Authors:  R L Then; R L Charnas; H P Kocher; M Manneberg; U Röthlisberger; J Stocker
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

7.  Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem.

Authors:  E H Lee; M H Nicolas; M D Kitzis; G Pialoux; E Collatz; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

8.  Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins.

Authors:  A Raimondi; A Traverso; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

9.  Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacae.

Authors:  K Bush; S K Tanaka; D P Bonner; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

10.  Diverse potential of beta-lactamase inhibitors to induce class I enzymes.

Authors:  D A Weber; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

View more
  6 in total

Review 1.  Antibiotic resistance: a current perspective.

Authors:  K F Barker
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

2.  Carbapenem resistance in a clinical isolate of Citrobacter freundii.

Authors:  J L Mainardi; P Mugnier; A Coutrot; A Buu-Hoï; E Collatz; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

3.  Imipenem resistance among gram-negative bacilli.

Authors:  J P Quinn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-03       Impact factor: 3.267

4.  Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.

Authors:  P A Bradford; C Urban; N Mariano; S J Projan; J J Rahal; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

5.  Imipenem resistance of enterobacter aerogenes mediated by outer membrane permeability.

Authors:  C Bornet; A Davin-Regli; C Bosi; J M Pages; C Bollet
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

6.  Relative importances of outer membrane permeability and group 1 beta-lactamase as determinants of meropenem and imipenem activities against Enterobacter cloacae.

Authors:  G Cornaglia; K Russell; G Satta; R Fontana
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.